79
Views
5
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens

, &
Pages 1679-1682 | Published online: 09 Jan 2014

References

  • Levine MM, Galen JE, Pasetti MF, Sztein MB. Attenuated strains of Salmonella enterica serovars Typhi and Paratyphi as live oral vaccines against enteric fever. In: New Generation Vaccines (4th Edition). Levine MM, Dougan G, Good MF et al (Eds.) Informa Healthcare, NY, USA, 497–505 (2010).
  • Dilts DA, Riesenfeld-Orn I, Fulginiti JP et al. Phase 1 clinical trials of aroAaroD and aroAaroDhtrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine18(15), 1473–1484 (2000).
  • Levine MM, Herrington D, Murphy JR et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest.79(3), 888–902 (1987).
  • Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine14(1), 19–24 (1996).
  • Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis.173(6), 1408–1414 (1996).
  • Kong Q, Six DA, Roland KL et al. Salmonella synthesizing 1-monophosphorylated lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J. Immunol.187(1), 412–423 (2011).
  • Roy MF, Lariviere L, Wilkinson R et al. Incremental expression of TLR4 correlates with mouse resistance to Salmonella infection and fine regulation of relevant immune genes. Genes Immun.7(5), 372–383 (2006).
  • Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol.3(7), 667–672 (2002).
  • Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci.65(20), 3231–3240 (2008).
  • Didierlaurent AM, Morel S, Lockman L et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol.183(10), 6186–6197 (2009).
  • Garcon N, Segal L, Tavares F, Van MM. The safety evaluation of adjuvants during vaccine development: the AS04 experience. Vaccine29(27), 4453–4459 (2011).
  • Khan S, Chatfield S, Stratford R et al. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine25(21), 4175–4182 (2007).
  • Tacket CO, Galen J, Sztein MB et al. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol.97(2), 146–153 (2000).
  • Curtiss R 3rd, Xin W, Li Y et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol.30(3), 255–270 (2010).
  • Li Y, Wang S, Scarpellini G et al. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl Acad. Sci. USA106(2), 593–598 (2009).
  • Wang S, Li Y, Scarpellini G et al. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun.78(9), 3969–3980 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.